Canadian Adverse Drug Reaction Newsletter

Murty, Mano; McMorran, Marielle; Vu, Duc
July 2001
CMAJ: Canadian Medical Association Journal;7/10/2001, Vol. 165 Issue 1, p81
Academic Journal
Presents information on adverse drug reactions. Health professional advisories available at the Web site from the Therapeutic Products Directorate; Possible serious adverse interaction between vaginal miconazole and warfarin; Hepatic, cardiac and hematological reactions associated with rosiglitazone (Avandia).


Related Articles

  • Drug advisory: the interaction between warfarin and vaginal miconazole. Wooltorton, Eric // CMAJ: Canadian Medical Association Journal;10/2/2001, Vol. 165 Issue 7, p938 

    Focuses on the warnings issued by the United States Food and Drug Administration and Health Canada that prothrombin times can increase for patients receiving antiocoagulation therapy who also use vaginal miconazole. Description of the interaction between warfarin and vaginal miconazole; Adverse...

  • Fluindione/miconazole interaction.  // Reactions Weekly;1/18/2014, Issue 1484, p19 

    The article presents a case study of a 79-year-old man with aphagia caused by aphthous stomatitis and developed increased anticoagulant activity of fluidione while receiving miconazole.

  • Drug points. Devaraj, A.; O'Beirne, J P; Veasey, R; Dunk, A A // BMJ: British Medical Journal (International Edition);7/13/2002, Vol. 325 Issue 7355, p77 

    Reports on the interaction between warfarin and topical miconazole cream. Possible increase of the anticoagulant effect of the warfarin by inhibiting hepatic microsomal cytochrome P-450 enzymes; Case of an elderly man who lost control of anticoagulation as a result of taking warfarin and...

  • Caution needed with concomitant miconazole gel and warfarin.  // Reactions Weekly;1/27/2007, Issue 1136, p2 

    The article considers the warning of Finland's National Agency for Medicines (NAM) regarding the use of miconazole or Daktarin oral gel in patients receiving warfarin. According to NAM the use of the oral gel may lead to increased International Normalized Ratio (INR) level. The article...

  • Pharmacovigilance for a Revolving World: Prospects of Patient-Generated Data on the Internet. NorĂ©n, G. // Drug Safety;Oct2014, Vol. 37 Issue 10, p761 

    The author discusses the technological feasibility of identifying references on possible adverse drug reactions in patient-generated data on the internet. Topics discussed include the varying nature of the sources of internet-data based data from a more detailed case descriptions and...

  • 'More side-effects' with dabigatran than warfarin.  // Pulse;5/23/2012, Vol. 72 Issue 19, p4 

    The article reports on the new analysis on anticoagulant dabigatran which was found out to have more complications and side-effects than warfarin.

  • RE-LY trial: both warfarin and dabigatran etexilate reduce GFR.  // Reactions Weekly;Jul2015, Vol. 1558 Issue 1, p11 

    The article reports that according to findings from the multinational RE-LY trial, long-term treatment with warfarin or dabigatran etexilate reduces the glomerular filtration rate.

  • Oxcarbazepine/warfarin interaction.  // Reactions Weekly;12/5/2009, Issue 1281, p25 

    The article describes the case of a boy who developed warfarin resistance while receiving treatment with oxcarbazepine. He was referred to a clinic for a low international normalized ratio (INR) despite receiving warfarin therapy. Oxcarbazepine was stopped but he was still admitted since his INR...

  • Warfarin.  // Reactions Weekly;11/15/2008, Issue 1228, p34 

    The article describes the case of an 85-year-old woman who developed a massive retropharyngeal haematoma while receiving warfarin as an anticoagulant in atrial fibrillation. After receiving warfarin, he collapsed and experienced difficulty breathing. She was given vitamin K and prothrombin...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics